Mitchell P. Kopin 13D/13G Filings for BioLineRx Ltd. (BLRX)

Mitchell P. Kopin 13D and 13G filings for BioLineRx Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-01-10
6:51 pm
Purchase		 2025-01-06 13G BioLineRx Ltd.
BLRX		 Mitchell P. Kopin 2,555,903
4.990%		 2,077,581increase
(+434.35%)		 Filing
2020-06-04
7:06 pm
Purchase		 2020-05-26 13G BioLineRx Ltd.
BLRX		 Mitchell P. Kopin 478,322
6.100%		 478,322increase
(New Position)		 Filing